Apatinib treatment efficiently delays biochemical-only recurrent ovarian cancer progression

• Main Authors: Zhongyu Wang (Author), Yake Huang (Author), Ling Long (Author), Li Zhou (Author), Yan Huang (Author), Lei Gan (Author), Aimin Pu (Author), Sufen Li (Author), Rongkai Xie (Author)
• Format: Book
• Published: BMC, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Biochemical recurrence is defined as only rising CA-125 but no radiographic evidence of disease; noteworthily, it generally precedes the onset of clinical evidence. Now treatment strategies of biochemical recurrence ovarian cancer (OC) remain controversial. Apatinib as monotherap...